Growth Metrics

Iridex (IRIX) Acquisitions (2011 - 2022)

Iridex's quarterly Acquisitions came in at -$5.3 million in Q4 2022, down 200.0% quarter-over-quarter from $5.3 million in Q2 2021.

Iridex has reported Acquisitions for 3 years, with the latest figure at -$5.3 million in Q4 2022.

  • For the quarter ending Q4 2022, Acquisitions changed N/A year-over-year to -$5.3 million; the trailing twelve-month figure through Oct 2021 stood at $5.3 million (changed N/A YoY), and the FY2022 full-year result was $5.3 million, changed N/A from the prior year.
  • Acquisitions for Q4 2022 stood at -$5.3 million, down from $5.3 million in the prior quarter.
  • The five-year high for Acquisitions was $5.3 million in Q2 2021, with the low at -$5.3 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Iridex 18.87 Mn 14.27 Mn 4.74 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 -5.34 Mn
Apr 3, 2021 5.34 Mn
Oct 1, 2011 -150,000.00